litlas
ログインアカウント作成

Dongsheng Tu

1987–2025 年に発表

127
論文数
35,595
被引用数
80
h 指数
117
i10 指数

被引用数

Dongsheng Tu の年別被引用数1974 年: 被引用 1 件1988 年: 被引用 5 件1989 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 4 件1992 年: 被引用 2 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 6 件1997 年: 被引用 8 件1998 年: 被引用 8 件1999 年: 被引用 17 件2000 年: 被引用 22 件2001 年: 被引用 16 件2002 年: 被引用 16 件2003 年: 被引用 22 件2004 年: 被引用 27 件2005 年: 被引用 98 件2006 年: 被引用 240 件2007 年: 被引用 312 件2008 年: 被引用 297 件2009 年: 被引用 354 件2010 年: 被引用 426 件2011 年: 被引用 369 件2012 年: 被引用 349 件2013 年: 被引用 354 件2014 年: 被引用 315 件2015 年: 被引用 281 件2016 年: 被引用 234 件2017 年: 被引用 266 件2018 年: 被引用 206 件2019 年: 被引用 641 件2020 年: 被引用 653 件2021 年: 被引用 625 件2022 年: 被引用 476 件2023 年: 被引用 369 件2024 年: 被引用 654 件2025 年: 被引用 356 件2026 年: 被引用 7 件1975〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,161 件、この内訳の 26.5%中国: 引用元論文 850 件、この内訳の 7.1%イギリス: 引用元論文 826 件、この内訳の 6.9%イタリア: 引用元論文 732 件、この内訳の 6.1%カナダ: 引用元論文 708 件、この内訳の 5.9%ドイツ: 引用元論文 626 件、この内訳の 5.3%フランス: 引用元論文 457 件、この内訳の 3.8%スペイン: 引用元論文 434 件、この内訳の 3.7%日本: 引用元論文 370 件、この内訳の 3.1%オーストラリア: 引用元論文 343 件、この内訳の 2.9%オランダ: 引用元論文 330 件、この内訳の 2.8%ベルギー: 引用元論文 250 件、この内訳の 2.1%
0%26.5%その他 23.8%

機関

分野

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology23.4%
  • Mathematics2.5%
  • Computer Science2.4%
  • Immunology and Microbiology1.8%
  • Economics, Econometrics and Finance0.9%
  • その他5.4%

トピック

  • Colorectal Cancer Treatments and Studies5.6%
  • Lung Cancer Treatments and Mutations5.3%
  • HER2/EGFR in Cancer Research3.2%
  • Cancer Genomics and Diagnostics3.1%
  • Breast Cancer Treatment Studies3.1%
  • Cancer Immunotherapy and Biomarkers2.8%
  • その他76.9%

共著者

全論文

検索で開く
  1. Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer

    著者: Eric X. Chen, Derek J. Jonker, Jonathan M. Loree, Hagen F. Kennecke, Scott Berry, Félix Couture, Chaudhary E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoît Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Alice C. Wei, Nadine M Magoski, Dongsheng Tu, Chris J. O’Callaghan - JAMA Oncology 2020 被引用: 398

  2. K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

    著者: Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker, Chris J. O’Callaghan, Dongsheng Tu, Niall C. Tebbutt, R. J. Simes, Haji Chalchal, Jeremy Shapiro, Sonia Robitaille, Timothy Price, Lois E. Shepherd, Heather‐Jane Au, Christiane Langer, Malcolm J. Moore, John Zalcberg - New England Journal of Medicine 2008 被引用: 3,597

  3. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

    著者: Marie Plante, Janice S. Kwon, Sarah E. Ferguson, Vanessa Samouëlian, Gwénaël Ferron, Amandine Maulard, Cor D. de Kroon, Willemien J. van Driel, John Tidy, Karin Williamson, Sven� Mahner, Stefan Kommoss, Frédéric Goffin, Karl Tamussino, Brynhildur Eyjólfsdóttir, Jae‐Weon Kim, Noreen Gleeson, Lori A. Brotto, Dongsheng Tu, Lois E. Shepherd - New England Journal of Medicine 2024 被引用: 252

  4. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    著者: Richard J. Gray, Rosie Bradley, Jeremy Braybrooke, Zulian Liu, Richárd Pető, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, William E. Barlow, Judith M. Bliss, Paolo Bruzzi, David Cameron, George Fountzilas, Sibylle Loibl, John R. Mackey, Miguel Martín, Lucia Del Mastro, Volker Möbus, Valentina Nekljudova, Sabino De Placido, Sandra M. Swain, Michael Untch, Kathleen I. Pritchard, Jonas Bergh, Larry Norton, Clare Boddington, Julie Ann Burrett, Mike Clarke, Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber ほか 67 名 - The Lancet 2019 被引用: 394

  5. The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

    著者: Daniel J. Renouf, Jonathan M. Loree, Jennifer J. Knox, James T. Topham, Petr Kavan, Derek J. Jonker, Stephen Welch, Félix Couture, Frédéric Lemay, Mustapha Tehfé, Mohammed Harb, Nathalie Aucoin, Yoo‐Joung Ko, Patricia A. Tang, Ravi Ramjeesingh, Brandon M. Meyers, Christina Kim, Pan Du, Shidong Jia, David F. Schaeffer, Sharlene Gill, Dongsheng Tu, Chris J. O’Callaghan - Nature Communications 2022 被引用: 139

  6. Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

    著者: John Hilton, Karen A. Gelmon, Philippe L. Bédard, Dongsheng Tu, Hong Xu, Anna V. Tinker, Rachel Goodwin, Scott A. Laurie, Derek J. Jonker, Aaron R. Hansen, Zachary Veitch, Daniel J. Renouf, Linda Hagerman, Hongbo Lui, Bingshu E. Chen, Deb Kellar, Irene Li, Sung‐Eun Lee, Takako Kono, Brian Yu Chieh Cheng, Damian Yap, Daniel Lai, Sean Beatty, John Soong, Kathleen I. Pritchard, Isabel Soria‐Bretones, Eric X. Chen, Harriet Feilotter, Moira Rushton, Lesley Seymour, Samuel Aparício, David W. Cescon - Nature Communications 2022 被引用: 145

  7. Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

    著者: Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu, Eng Huat Tan, Vera Hirsh, Sumitra Thongprasert, Daniel de Castro, Savitree Maoleekoonpiroj, Michael Smylie, Renato Martins, Maximiliano Van Kooten, Mircea Dediu, B. Findlay, Dongsheng Tu, D. Johnston, Andrea Bezjak, Gary M. Clark, P. Santabárbara, Lesley Seymour - New England Journal of Medicine 2005 被引用: 5,451

  8. Cetuximab for the Treatment of Colorectal Cancer

    著者: Derek J. Jonker, Chris J. O’Callaghan, Christos S. Karapetis, John Zalcberg, Dongsheng Tu, Heather-Jane Au, Scott Berry, Marianne Krahn, Timothy Price, R. J. Simes, Niall C. Tebbutt, Guy van Hazel, Rafal Wierzbicki, Christiane Langer, Malcolm J. Moore - New England Journal of Medicine 2007 被引用: 1,806

  9. Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

    著者: Arjun Gupta, Christopher J. O’Callaghan, Liting Zhu, Derek J. Jonker, Ralph Wong, Bruce Colwell, Malcolm J. Moore, Christos S. Karapetis, Niall C. Tebbutt, Jeremy Shapiro, Dongsheng Tu, Christopher M. Booth - JCO Oncology Practice 2023 被引用: 69

  10. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    著者: Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Nicholas J. Robert, Hyman B. Muss, Julie R. Gralow, Karen A. Gelmon, Timothy J. Whelan, Kathrin Strasser‐Weippl, S. Rubin, Keren Sturtz, Antonio C. Wolff, Eric P. Winer, Clifford A. Hudis, Alison Stopeck, J. Thaddeus Beck, Judith S. Kaur, Kate Whelan, Dongsheng Tu, Wendy R. Parulekar - New England Journal of Medicine 2016 被引用: 648

  11. Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    著者: Paul E. Goss, James N. Ingle, José E. Alés‐Martínez, Angela M. Cheung, Rowan T. Chlebowski, Jean Wactawski‐Wende, Anne McTiernan, John A. Robbins, Karen Johnson, Lisa W. Martin, Eric Winquist, Gloria E. Sarto, Judy E. Garber, Carol J. Fabian, Pascal Pujol, Elizabeth Maunsell, Patricia Farmer, Karen A. Gelmon, Dongsheng Tu, Harriet Richardson - New England Journal of Medicine 2011 被引用: 961

  12. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

    著者: Tingyan Shi, Jianqing Zhu, Yanling Feng, Dongsheng Tu, Yuqin Zhang, Zhang Ping, Huixun Jia, Xiao Huang, Yunlang Cai, Sheng Yin, Rong Jiang, Wenjuan Tian, Wen Gao, Jihong Liu, Huijuan Yang, Xi Cheng, Rongyu Zang - The Lancet Oncology 2021 被引用: 227

  13. Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer

    著者: Eric X. Chen, Jonathan M. Loree, Emma Titmuss, Derek J. Jonker, Hagen F. Kennecke, Scott Berry, Félix Couture, Chaudharry E. Ahmad, John R. Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoît Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Alice C. Wei, Dongsheng Tu, Chris J. O’Callaghan - JAMA Network Open 2023 被引用: 64

  14. Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial

    著者: Derek J. Jonker, Louise Nott, Takayuki Yoshino, Sharlene Gill, Jeremy Shapiro, Atsushi Ohtsu, John Zalcberg, Michael M. Vickers, Alice C. Wei, Yuan Gao, Niall C. Tebbutt, Ben Markman, Timothy Price, Taito Esaki, Sheryl Koski, Matthew Hitron, Wěi Li, Youzhi Li, Nadine M Magoski, Chiang J. Li, John Simes, Dongsheng Tu, Christopher J. O’Callaghan - ˜The œLancet. Gastroenterology & hepatology 2018 被引用: 168

  15. Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial

    著者: Quincy S. Chu, Federica Perrone, Laurent Greillier, Wei Tu, Maria Carmela Piccirillo, Federica Grosso, Giuseppe Lo Russo, Marie Florescu, Manlio Mencoboni, Alessandro Morabito, Fabiana Letizia Cecere, Giovanni Luca Ceresoli, David E. Dawe, Paolo Andrea Zucali, Maria Pagano, John R. Goffin, Myriam Locatelli Sanchez, Cesare Gridelli, Gérard Zalcman, Xavier Quantin, Virginie Westeel, Piera Gargiulo, Sara Delfanti, Dongsheng Tu, Christopher W. Lee, Natasha B. Leighl, Joana Sederias, Pamela Brown-Walker, Yiwen Luo, Sylvie Lantuéjoul, Ming‐Sound Tsao, Arnaud Scherpereel, Penelope A. Bradbury, Scott A. Laurie, Lesley Seymour - The Lancet 2023 被引用: 101

  16. Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

    著者: Maggie C.U. Cheang, Miguel Martín, Torsten O. Nielsen, Aleix Prat, David Voduc, Álvaro Rodríguez-Lescure, Amparo Ruı́z, Stephen Chia, Lois E. Shepherd, Manuel Ruíz‐Borrego, Lourdes Calvo, Emilio Alba, Eva Carrasco, Rosalía Caballero, Dongsheng Tu, Kathleen I. Pritchard, Mark N. Levine, Vivien Bramwell, Joel S. Parker, Philip S. Bernard, Matthew J. Ellis, Charles M. Perou, Angelo Di Leo, Lisa A. Carey - The Oncologist 2015 被引用: 198

  17. Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer

    著者: James T. Topham, Chris J. O’Callaghan, Harriet Feilotter, Hagen F. Kennecke, Young S. Lee, Weimin Li, Kimberly C. Banks, Katie Quinn, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Eric X. Chen, Jonathan M. Loree - Journal of Clinical Oncology 2022 被引用: 67

  18. Morphine, Gabapentin, or Their Combination for Neuropathic Pain

    著者: Ian Gilron, Joan M. Bailey, Dongsheng Tu, Ronald R. Holden, Donald F. Weaver, Robyn L. Houlden - New England Journal of Medicine 2005 被引用: 1,088

  19. Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

    著者: Wendy De Roock, Derek J. Jonker, Federica Di Nicolantonio, Andrea Sartore‐Bianchi, Dongsheng Tu, Salvatore Siena, Simona Lamba, Sabrina Arena, Milo Frattini, Hubert Piessevaux, Eric Van Cutsem, Chris J. O’Callaghan, Shirin Khambata‐Ford, John Zalcberg, John Simes, Christos S. Karapetis, Alberto Bardelli, Sabine Tejpar - JAMA 2010 被引用: 747

  20. The Jackknife and Bootstrap

    著者: Jun Shao, Dongsheng Tu - Springer series in statistics 1995 被引用: 1,994

  21. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

    著者: Stephanie Yasmin Brule, Derek J. Jonker, Christos S. Karapetis, Chris J. O’Callaghan, Malcolm J. Moore, Ralph Wong, Niall C. Tebbutt, Craig Underhill, Desmond Yip, John Zalcberg, Dongsheng Tu, Rachel Goodwin - European Journal of Cancer 2015 被引用: 337

  22. Phase II study of PX-866 in recurrent glioblastoma

    著者: Marshall Pitz, Elizabeth A. Eisenhauer, Mary MacNeil, Brian Thiessen, Jacob C. Easaw, David R. Macdonald, David D. Eisenstat, Ankineedu Saranya Kakumanu, Muhammad Salim, Haji Chalchal, Jeremy A. Squire, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Shantanu Banerji, Dongsheng Tu, Jean Powers, Diana F. Hausman, Warren Mason - Neuro-Oncology 2015 被引用: 119

  23. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials

    著者: Divine Ediebah, Chantal Quinten, Corneel Coens, Jolie Ringash, Janet Dancey, Efstathios Zikos, Carolyn Gotay, Michael Brundage, Dongsheng Tu, Hans‐Henning Flechtner, Eva Greimel, Bryce B. Reeve, Martin Taphoorn, Jaap C. Reijneveld, Linda Dirven, Andrew Bottomley - Cancer 2018 被引用: 99

  24. A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen

    著者: Stephen Chia, Vivien Bramwell, Dongsheng Tu, Lois E. Shepherd, Shan Jiang, Tammi L. Vickery, Elaine R. Mardis, Samuel Leung, Karen Ung, Kathleen I. Pritchard, Joel S. Parker, Philip S. Bernard, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen - Clinical Cancer Research 2012 被引用: 310